Drugs / Tumor lysate-pulsed dendritic cell (DC) vaccine
Tumor lysate-pulsed dendritic cell (DC) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00405327 | Jun 2006 → Jun 2009 | Wilms tumor, neuroblastoma, sarcoma | University of Michigan Rogel Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor lysate-pulsed dendritic cell (DC) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00405327 ↗ |
| Modality | Vaccine | “Tumor lysate-pulsed dendritic cell vaccine” NCT00405327 ↗ |